|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00566306 |
|
Date of registration:
|
30/11/2007 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation
|
|
Scientific title:
|
Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation |
|
Date of first enrolment:
|
February 2007 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00566306 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Mari Kanerva, MD,PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Helsinki University Central Hospital, Department of Medicine, Division of Infectious Diseases |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria: ( classified as a HCF-onset, HCF-associated CDAD )
- toxin or culture positive C difficile
- symptom onset more than 72 hours after admission to hospital
- symptom onset less than 4 weeks after discharge
Exclusion Criteria:
- recurrence of CDAD within 8 weeks
- symptom onset before admission to hospital or less than 72 hours after admission to
hospital
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Clostridium Difficile
|
|
Intervention(s)
|
|
Other: Polyhexamethyleneguanidine (PHMG)
|
|
Primary Outcome(s)
|
|
Clinical: C. difficile infections on study wards. Microbiologic: C difficile colonization.
[Time Frame: 2/07-5/08]
|
|
Secondary Outcome(s)
|
|
Economical: to evaluate cost of C difficile infection
[Time Frame: 2/07-5/08]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|